Data / Form D filings / Inherent Biosciences, Inc.
Inherent Biosciences, Inc.: Form D filing
Inherent Biosciences, Inc., a biotechnology company in Salt Lake City, UT, filed a Form D with the SEC in 2023. The latest, on May 31, 2023, reports $1.5 million sold of an offering with no set size to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 26 S RIO GRANDE STREET #2072, Salt Lake City, UT, 84101
- Phone
- (509) 496-1204
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1977505
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 31, 2023 | New notice | Indefinite | $1,513,869 | 12 | Aug 19, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew Olson | Executive Officer |
Other biotechnology companies in Utah that filed recently
- Life Impact Partners 1 LLC offering · Oct 22, 2026
- 3Helix, Inc. $7.8 million · Sep 21, 2026
- Halia Therapeutics, Inc. $3.5 million · Aug 31, 2026
- Paterna BioSciences HoldCo Inc. $6.3 million · Aug 12, 2026
Every Form D from the week of May 29, 2023 · All recent filings in Utah · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Inherent Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.